Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1.39B
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
20.4M
-
Shares change
-
+2.79M
-
Total reported value, excl. options
-
$918M
-
Value change
-
+$131M
-
Number of buys
-
34
-
Number of sells
-
-25
-
Price
-
$45.00
Significant Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q2 2017
65 filings reported holding ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share as of Q2 2017.
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.4M shares
of 1.39B outstanding shares and own 1.47% of the company stock.
Largest 10 shareholders include FMR LLC (3.99M shares), Hillhouse Capital Management, Ltd. (3.72M shares), BAKER BROS. ADVISORS LP (3.67M shares), WELLINGTON MANAGEMENT GROUP LLP (1.48M shares), ORBIMED ADVISORS LLC (1.29M shares), PRICE T ROWE ASSOCIATES INC /MD/ (906K shares), OppenheimerFunds, Inc. (716K shares), Boxer Capital, LLC (600K shares), BROWN ADVISORY INC (482K shares), and Artal Group S.A. (400K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.